)
Eswar Iyer
CEO & Co-Founder,
Aikium
Eswar leads Aikium, where AI and synthetic biology converge to tackle targets once thought undruggable. He brings a track record of building high-impact technologies, advising on $480M+ in M&A, and contributing to over 100 patents across AI, multiomics, and protein engineering.
Trained under Prof. George Church at Harvard Medical School, Eswar combines deep technical insight with strategic vision to accelerate the future of therapeutic discovery.